SEC 'Shadow Trading' Case Survives Exec's Early Win Bid
A former pharmaceutical executive could not secure summary judgment in a novel U.S. Securities and Exchange Commission "shadow trading" case, with a California federal judge ruling Monday that the SEC has...To view the full article, register now.
Already a subscriber? Click here to view full article